CELULARITY
LIVE

Serial Number

90002793

Owner

CELULARITY INC.

Attorney

Camille M. Miller

First Use Date

Dec 6, 2018

Filing Date

Jun 15, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CELULARITY Trademark

Serial Number: 90002793 • Registration: 6260135

CELULARITY is a trademark filed by CELULARITY INC. on June 15, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CELULARITY INC.

170 PARK AVENUE
FLORHAM PARK, NJ 07932

Entity Type: 03

CELENIV PTE. LTD. (13 trademarks)

3, LIM TECK KIM ROAD
SINGAPORE 088934 , SG

Entity Type: 11

Celularity, Inc.

Florham Park, NJ 07932

Entity Type: 03

Trademark Details

Filing Date

June 15, 2020

Registration Date

February 2, 2021

First Use Anywhere

December 6, 2018

First Use in Commerce

December 6, 2018

Published for Opposition

November 17, 2020

Goods & Services

Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen;biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen

bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 2, 2026 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 7, 2026 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 12, 2022 ASGN
REGISTERED-PRINCIPAL REGISTER
Feb 2, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 17, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 17, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 28, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 9, 2020 CNSA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 8, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 8, 2020 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 8, 2020 COAR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 15, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 7, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 7, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 7, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 5, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 14, 2020 NWOS
NEW APPLICATION ENTERED
Jun 18, 2020 NWAP